858 results match your criteria: "Hermansky-Pudlak Syndrome"

Hermansky-Pudlak syndrome (HPS) is a genetic disorder of endosomal protein trafficking associated with pulmonary fibrosis in specific subtypes, including HPS-1 and HPS-2. Single mutant HPS1 and HPS2 mice display increased fibrotic sensitivity while double mutant HPS1/2 mice exhibit spontaneous fibrosis with aging, which has been attributed to HPS mutations in alveolar epithelial type II (AT2) cells. We utilized HPS mouse models and human lung tissue to investigate mechanisms of AT2 cell dysfunction driving fibrotic remodeling in HPS.

View Article and Find Full Text PDF

Molecular basis of platelet granule defects.

J Thromb Haemost

November 2024

Cell Biology Program, Research Institute, Hospital for Sick Children, Toronto, ON, M5G 0A4, Canada; Department of Biochemistry, University of Toronto, Toronto, ON, M5S 1A8, Canada; Division of Haematology/Oncology, Department of Paediatrics, University of Toronto and The Hospital for Sick Children, Toronto, ON, M5G 1X8, Canada. Electronic address:

Platelets are small, discoid, anucleate blood cells that play key roles in clotting and other functions involved in health and disease. Platelets are derived from bone marrow-resident megakaryocytes, which undergo a complex developmental process where they increase dramatically in size and produce an abundance of organelles destined for platelets. These organelles include mitochondria, lysosomes, peroxisomes and two unique types of secretory organelle: α and dense (δ) granules.

View Article and Find Full Text PDF

Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder characterized by oculocutaneous albinism, bleeding diathesis, and multiorgan involvement. Granulomatous enterocolitis may occur in a subset of patients. Distinguishing HPS from other diseases such as Crohn's disease can be challenging, and managing HPS-associated colitis is complex.

View Article and Find Full Text PDF
Article Synopsis
  • Primary immunodeficiency diseases with partial albinism, such as Chediak Higashi Syndrome (CHS) and Griscelli Syndrome type 2 (GS2), are autosomal recessive disorders characterized by immune deficiencies and abnormal pigmentation.
  • The study evaluated 25 patients over the past decade, using genetic analyses and examinations of leukocyte granules and hair shafts to identify these conditions, along with control groups of patients with albinism and healthy individuals.
  • The findings indicated specific genetic variants associated with CHS and HPS2, highlighting the importance of timely hematopoietic stem cell transplantation and genetic testing for accurate diagnosis and management of these syndromes.
View Article and Find Full Text PDF

Hermansky-Pudlak syndrome (HPS)-associated pulmonary fibrosis (HPS-PF) is a progressive lung disease that is a major cause of morbidity and mortality in HPS patients. Previous studies have demonstrated that the HPS proteins play an essential role in the biogenesis and function of lysosome-related organelles (LROs) in alveolar epithelial type II (AT2) cells and found that HPS-PF is associated with dysfunction of AT2 cells and abnormal immune reactions. Despite recent advances in research on HPS and the pathology of HPS-PF, the pathological mechanisms underlying HPS-PF remain poorly understood, and no effective treatment has been established.

View Article and Find Full Text PDF

Hermansky-Pudlak syndrome (HPS) is a rare disease inherited in the autosomal recessive mode, including 11 clinical genetic subtypes. They are associated with impaired function of the BLOC protein complex (Biogenesis of Lysosome-related Organelles Complexes), and the subunits of the AP-3 complex (adaptor protein complex). Each has its own clinical features, but they are all characterized by albinism, bleeding disorder, and visual abnormalities.

View Article and Find Full Text PDF
Article Synopsis
  • Interstitial lung diseases (ILDs) include over 200 types, with a growing focus on fibrosing lung diseases due to new therapies, but less common ILDs also need attention because of their poor prognosis.
  • This review provides an updated overview of rare ILDs, including idiopathic interstitial pneumonias, genetic disorders like Hermansky-Pudlak syndrome, and conditions associated with lymphoid tissue proliferation, such as follicular bronchiolitis.
  • Despite their rarity, improved recognition of imaging and pathology is enhancing our understanding, but these ILDs still pose diagnostic challenges and lack established treatments, highlighting the need for more research.
View Article and Find Full Text PDF

Hermansky-Pudlak syndrome (HPS), both alone and in conjunction with pulmonary fibrosis (HPS-PF), is a rare, genetically heterogeneous, autosomal recessive disorder that affects multiple organs, including the lungs. In cases of HPS-PF, pulmonary fibrosis is preceded by local inflammation. We present a case of HPS-PF that exhibited histological evidence of extracellular traps (ETs) ensnaring macrophages, leading to cell death in a process known as ETosis.

View Article and Find Full Text PDF
Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) types 1 and 4 lead to serious lung issues like pulmonary fibrosis, but the exact causes are still unclear.
  • This research focused on how interactions between CHI3L1 and a type of immune cell (ILC2s) affect pulmonary fibrosis in HPS and involved experiments with mice to explore these interactions.
  • The results indicated that ILC2s may enhance fibroblast activity and fibrosis through specific signaling pathways, suggesting that these immune cells play a critical role in the progression of lung scarring in HPS.
View Article and Find Full Text PDF

Hermansky-Pudlak Syndrome: An unusual pattern of pulmonary fibrosis.

Respir Med Case Rep

September 2024

Department of Respiratory Medicine, Alfred Health, Melbourne, Australia.

Hermansky-Pudlak Syndrome is a rare genetic cause of pulmonary fibrosis, associated with albinism, nystagmus, and a bleeding diathesis. Histologically, Hermansky-Pudlak Syndrome Pulmonary Fibrosis (HPS-PF) typically resembles usual interstitial pneumonia (UIP), however radiologically this is not always the case with a range of features described in the current literature. HPS-PF typically occurs earlier in life than idiopathic pulmonary fibrosis (IPF) and there is limited evidence to support the use of antifibrotic therapy.

View Article and Find Full Text PDF

Impairment of Renal Function in Hermansky-Pudlak Syndrome.

Am J Nephrol

October 2024

Section of Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that impacts the development of lysosome-related organelles, leading to varied clinical symptoms based on its genetic type, with HPS-1 and HPS-4 being more severe compared to HPS-3, HPS-5, and HPS-6.
  • This study aimed to improve understanding of kidney issues associated with HPS, using medical records and renal function tests from patients evaluated at the National Institutes of Health from 1995 to 2020.
  • Results showed that adults with HPS-1 and HPS-4 had significantly lower kidney function compared to those with HPS-3, HPS-5, or HPS-6
View Article and Find Full Text PDF
Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that causes oculocutaneous albinism, bleeding issues, and can lead to serious complications like lung fibrosis and colitis.
  • A case report discusses a 63-year-old woman with HPS type 1 who experienced acute angle closure glaucoma after cataract surgery, resulting in severe pain in her right eye.
  • The preoperative care included aminocaproic acid to reduce bleeding risks, and a YAG laser iridotomy was performed to lower eye pressure and stabilize her condition.
View Article and Find Full Text PDF
Article Synopsis
  • Hermansky-Pudlak Syndrome (HPS) is a rare genetic disorder with symptoms including oculocutaneous albinism, bleeding issues, and potential lung and bowel complications, linked to mutations in genes critical for cellular transport.
  • The study specifically focuses on HPS-9, associated with a variant in the BLOC1S6 gene, highlighting a novel Copy Number Variation (CNV) found in an Iranian family, which contributes to the understanding of this subtype's genetic basis.
  • Results from Whole Exome Sequencing revealed a significant deletion in the BLOC1S6 gene, confirming the absence of its expression in affected individuals, which has implications for patient healthcare and future treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a rare genetic condition with multiple system effects, inherited in an autosomal recessive manner, primarily due to mutations that impact lysosomal function.
  • It is characterized by symptoms such as oculocutaneous albinism, bleeding disorders from platelet storage issues, lung fibrosis, and colitis.
  • A case report detailed a two-year-old boy diagnosed with HPS type 2, showing signs of albinism and skin lesions, along with recurrent nosebleeds, confirmed by genetic testing indicating a specific gene mutation.
View Article and Find Full Text PDF

Hermansky-Pudlak syndrome (HPS) is a genetic multisystemic disorder with oculocutaneous albinism, granulomatous colitis, bleeding diathesis, and pulmonary fibrosis. Multiple subtypes of HPS exist, with certain types having higher predilection for pulmonary fibrosis. This case report focuses on the demonstration of pulmonary imaging findings seen in a patient.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used whole exome sequencing to study nine Pakistani families with OCA, identifying pathogenic gene variants through advanced sequencing techniques and analysis tools.
  • * The study discovered specific gene variants in TYR, OCA2, and HPS1, including two new mutations, enhancing understanding of OCA's genetic basis and aiding in better management for affected families in Pakistan.
View Article and Find Full Text PDF

Biogenesis of lysosome-related organelles complex-2 is an evolutionarily ancient proto-coatomer complex.

Curr Biol

August 2024

School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK; Division of Cell & Developmental Biology, University College London, London WC1E 6BT, UK. Electronic address:

Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a genetic disorder that disrupts the function of lysosome-related organelles (LROs) due to mutations in at least 11 genes, with BLOC-2 being a complex whose function is still unclear.
  • Researchers discovered that the single-celled organism Dictyostelium has a complete version of BLOC-2, with similarities to mammalian and Drosophila proteins that are essential for LRO biogenesis.
  • The study reveals that BLOC-2's recruitment and function in lysosomes are crucial, suggesting that LROs have existed before the evolution of multicellular organisms and indicating a more essential role than previously recognized.
View Article and Find Full Text PDF
Article Synopsis
  • Albinism is a condition with varying degrees of pigmentation loss in skin, hair, and eyes, and one form, Hermansky-Pudlak syndrome (HPS), also includes bleeding issues due to defective platelets.
  • A case study on Puerto Rican siblings with albinism revealed they did not possess the typical HPS gene mutations, prompting further genetic analysis.
  • The siblings were found to have multiple variants in the Tyrosinase gene, leading to a diagnosis of Oculocutaneous Albinism type 1B (OCA1B), highlighting the need for molecular testing in rare genetic disorders.
View Article and Find Full Text PDF

Genetic screening reveals hotspot variants and prevalence rates of Hermansky-Pudlak syndrome in the Chinese population.

Clin Chim Acta

July 2024

Beijing Key Laboratory for Genetics of Birth Defects, Beijing Pediatric Research Institute, MOE Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Henan Key Laboratory of Inherited Metabolic Diseases, Pediatric Research Institute of Zhengzhou Children's Hospital, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, Henan 450053, China. Electronic address:

Article Synopsis
  • Hermansky-Pudlak Syndrome (HPS) is a rare genetic disorder characterized by symptoms like albinism and bleeding issues, making early diagnosis vital for effective treatment and genetic counseling.
  • In a study involving genetic screening of nearly 30,000 newborns across 13 provinces in China, researchers identified 215 carriers of 103 distinct pathogenic variants of HPS, including some unique to the Chinese population.
  • The findings revealed a prevalence rate of approximately 2.84 cases per million in China, highlighting significant genetic insights that can improve diagnosis and management of HPS.
View Article and Find Full Text PDF
Article Synopsis
  • * Deficiencies in pulmonary surfactants can result in various respiratory and immune disorders, highlighting the importance of LBs in maintaining respiratory health.
  • * The study found that a lack of HPS6, a key component in the formation of LBs, disrupts the acidity and size of LBs, impacting the overall homeostasis and function of these organelles, shedding light on their potential pathology.
View Article and Find Full Text PDF

Anandamide is an Early Blood Biomarker of Hermansky-Pudlak Syndrome Pulmonary Fibrosis.

medRxiv

May 2024

Section of Human Biochemical Genetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

Article Synopsis
  • Hermansky-Pudlak syndrome (HPS) is a rare genetic condition linked to severe lung issues, particularly pulmonary fibrosis, with no effective treatments available.
  • The study analyzed endocannabinoids in blood samples from HPS patients and other groups to see if they could serve as early indicators of lung fibrosis, noting an increase in the endocannabinoid anandamide (AEA) in HPS-1 patients.
  • A treatment involving zevaquenabant was found to reduce elevated AEA levels and slow down lung fibrosis progression in mouse models, suggesting that AEA could be a potential blood biomarker for monitoring PF in HPS.
View Article and Find Full Text PDF
Article Synopsis
  • A report discusses a 43-year-old Japanese woman diagnosed with Hermansky-Pudlak syndrome (HPS), exhibiting respiratory issues like cough and difficulty breathing.
  • High-resolution CT scans showed abnormal lung patterns, and her diagnosis was confirmed through a prolonged bleeding time and a mutation in the HPS1 gene.
  • Treatment with pirfenidone led to improvements in her respiratory symptoms, suggesting that it may be a viable option for patients with HPS awaiting lung transplantation.
View Article and Find Full Text PDF